352 related articles for article (PubMed ID: 16822720)
21. Suppression of IL-1beta expression by the Jak 2 inhibitor AG490 in cerulein-stimulated pancreatic acinar cells.
Yu JH; Kim KH; Kim H
Biochem Pharmacol; 2006 Nov; 72(11):1555-62. PubMed ID: 16934228
[TBL] [Abstract][Full Text] [Related]
22. Pressure overload-induced cardiac hypertrophy response requires janus kinase 2-histone deacetylase 2 signaling.
Ying H; Xu MC; Tan JH; Shen JH; Wang H; Zhang DF
Int J Mol Sci; 2014 Nov; 15(11):20240-53. PubMed ID: 25380525
[TBL] [Abstract][Full Text] [Related]
23. Olmesartan attenuates cardiac remodeling through DLL4/Notch1 pathway activation in pressure overload mice.
You J; Wu J; Jiang G; Guo J; Wang S; Li L; Ge J; Zou Y
J Cardiovasc Pharmacol; 2013 Feb; 61(2):142-51. PubMed ID: 23188126
[TBL] [Abstract][Full Text] [Related]
24. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
[TBL] [Abstract][Full Text] [Related]
25. Blockage of JAK/STAT signalling attenuates renal ischaemia-reperfusion injury in rat.
Yang N; Luo M; Li R; Huang Y; Zhang R; Wu Q; Wang F; Li Y; Yu X
Nephrol Dial Transplant; 2008 Jan; 23(1):91-100. PubMed ID: 17670769
[TBL] [Abstract][Full Text] [Related]
26. Polydatin prevents hypertrophy in phenylephrine induced neonatal mouse cardiomyocytes and pressure-overload mouse models.
Dong M; Ding W; Liao Y; Liu Y; Yan D; Zhang Y; Wang R; Zheng N; Liu S; Liu J
Eur J Pharmacol; 2015 Jan; 746():186-97. PubMed ID: 25449040
[TBL] [Abstract][Full Text] [Related]
27. Metallothionein mediates cardioprotection of isoliquiritigenin against ischemia-reperfusion through JAK2/STAT3 activation.
An W; Yang J; Ao Y
Acta Pharmacol Sin; 2006 Nov; 27(11):1431-7. PubMed ID: 17049118
[TBL] [Abstract][Full Text] [Related]
28. Cardiac hypertrophy is enhanced in PPAR alpha-/- mice in response to chronic pressure overload.
Smeets PJ; Teunissen BE; Willemsen PH; van Nieuwenhoven FA; Brouns AE; Janssen BJ; Cleutjens JP; Staels B; van der Vusse GJ; van Bilsen M
Cardiovasc Res; 2008 Apr; 78(1):79-89. PubMed ID: 18187461
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction: role of TGF-β1-TAK1.
Li Q; Xu Y; Li X; Guo Y; Liu G
Toxicol Lett; 2012 Jun; 211(2):91-7. PubMed ID: 22465603
[TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor beta protects the murine heart against left ventricular hypertrophy.
Babiker FA; Lips D; Meyer R; Delvaux E; Zandberg P; Janssen B; van Eys G; Grohé C; Doevendans PA
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1524-30. PubMed ID: 16627800
[TBL] [Abstract][Full Text] [Related]
31. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
[TBL] [Abstract][Full Text] [Related]
32. Cardioprotection of exogenous erythropoietin in mice with ligature-induced aortic stenosis: effects on maladaptive cardiac hypertrophy.
Zheng L; Xu J; Qiu W; Liu X; Zhao CM; Chen D; Chen Y
J Physiol Pharmacol; 2010 Feb; 61(1):13-20. PubMed ID: 20228410
[TBL] [Abstract][Full Text] [Related]
33. Cardioprotective effect of ghrelin against myocardial infarction-induced left ventricular injury via inhibition of SOCS3 and activation of JAK2/STAT3 signaling.
Eid RA; Alkhateeb MA; Eleawa S; Al-Hashem FH; Al-Shraim M; El-Kott AF; Zaki MSA; Dallak MA; Aldera H
Basic Res Cardiol; 2018 Feb; 113(2):13. PubMed ID: 29392420
[TBL] [Abstract][Full Text] [Related]
34. IL-6 regulates MMP-10 expression via JAK2/STAT3 signaling pathway in a human lung adenocarcinoma cell line.
Zhang X; Yin P; DI D; Luo G; Zheng L; Wei J; Zhang J; Shi Y; Zhang J; Xu N
Anticancer Res; 2009 Nov; 29(11):4497-501. PubMed ID: 20032397
[TBL] [Abstract][Full Text] [Related]
35. Modified citrus pectin prevents isoproterenol-induced cardiac hypertrophy associated with p38 signalling and TLR4/JAK/STAT3 pathway.
Li Y; Zhou WW; Sun JH; Yang HX; Xu GR; Zhang Y; Song QH; Zhang C; Liu WZ; Liu XC; Li AY
Biomed Pharmacother; 2021 Nov; 143():112178. PubMed ID: 34649308
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of IκB phosphorylation prevents load-induced cardiac dysfunction in mice.
Tanaka T; Ogawa M; Suzuki J; Sekinishi A; Itai A; Hirata Y; Nagai R; Isobe M
Am J Physiol Heart Circ Physiol; 2012 Dec; 303(12):H1435-45. PubMed ID: 23042949
[TBL] [Abstract][Full Text] [Related]
37. JAK2 tyrosine kinase inhibitor AG490 suppresses cell growth and invasion of gallbladder cancer cells via inhibition of JAK2/STAT3 signaling.
Fu LX; Lian QW; Pan JD; Xu ZL; Zhou TM; Ye B
J Biol Regul Homeost Agents; 2017; 31(1):51-58. PubMed ID: 28337870
[TBL] [Abstract][Full Text] [Related]
38. Impaired JAK2-induced activation of STAT3 in failing human myocytes.
Cambi GE; Lucchese G; Djeokeng MM; Modesti A; Fiaschi T; Faggian G; Sani G; Modesti PA
Mol Biosyst; 2012 Sep; 8(9):2351-9. PubMed ID: 22735740
[TBL] [Abstract][Full Text] [Related]
39. AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway.
Meng R; Pei Z; Zhang A; Zhou Y; Cai X; Chen B; Liu G; Mai W; Wei J; Dong Y
Arch Biochem Biophys; 2011 Jul; 511(1-2):1-7. PubMed ID: 21530483
[TBL] [Abstract][Full Text] [Related]
40. Eplerenone prevents adverse cardiac remodelling induced by pressure overload in atrial natriuretic peptide-null mice.
Franco V; Chen YF; Feng JA; Li P; Wang D; Hasan E; Oparil S; Perry GJ
Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):773-9. PubMed ID: 16922805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]